Conclusion: These guidelines provide evidence-based recommendations for the management of acne vulgaris.
PubMed 38300170 ↗Tretinoin
Also known as Retin-A
The short answer. Most people who report on Tretinoin say it helped (91% of 23). It is most often used for skin & hair: 91% of 35 reports say that improved. It is well studied — 76 meta-analyses on PubMed.
From 50 mentions in total — the rest didn't say how it went and aren't counted.
What Tretinoin does, according to users
Of the people who reported each effect, the share who said it got better.
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 76 meta-analyses on PubMed ↗ · 265 randomized trials ↗
Conclusion: oral minoxidil, finasteride, dutasteride), and procedural (e.g. platelet-rich plasma, fractionated lasers, hair transplantation) treatments successfully promote hair growth, highlighting the superiority of a multifaceted and individualized approach to management.
PubMed 38852607 ↗Conclusion: Hydroquinone monotherapy and triple combination cream are the most effective and well-studied treatments for melasma, whereas chemical peels and laser- and light-based therapies are equal or inferior to topicals, but offer a higher risk of adverse effects. Oral tranexamic acid may be a safe, systemic adjunctive treatment for melasma, but more studies are needed to determine its long-term safety and efficacy. Limitations of the current evidence are heterogeneity of study design, small sample size, and lack of long-term follow-up, highlighting the need for larger, more rigorous studies in the tr
PubMed 31802394 ↗Conclusion: In this systematic review we present information relating to the effectiveness and safety of the following interventions: topical treatments (adapalene, azelaic acid, benzoyl peroxide, clindamycin, erythromycin [alone or plus zinc]; isotretinoin, tetracycline, tretinoin); and oral treatments (doxycycline, isotretinoin, lymecycline, minocycline, oxytetracycline, tetracycline).
PubMed 21477388 ↗405 human trials on ClinicalTrials.gov test Tretinoin — 223 completed, 27 recruiting now. See all on ClinicalTrials.gov ↗
- Outcomes of the A.S.A.P. Algorithm for Keloids: A Controlled Prospective Study · Keloid · 2026
- Therapy for Children With Advanced Stage Neuroblastoma · Neuroblastoma · 2025
- Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refractory Melanoma (MK-3475-02A/KEYMAKER-U02) · Melanoma · 2025
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
Boxed warning (the FDA's strongest label warning): “EMBRYO-FETAL TOXICITY and DIFFERENTIATION SYNDROME Tretinoin capsules can cause embryo-fetal loss and malformations when administered to a pregnant woman. Advise pregnant women of the potential risk to a fetus. Females of reproductive potential must have a negative pregnancy test before initiating…”
7 recalls of products named for Tretinoin. Most recent:
- 2022-06-29 · Class II: Failed Dissolution Specifications; Low Out of Specification (OOS) results for dissolution. record ↗
- 2022-02-09 · Class II: Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution. record ↗
- 2020-04-22 · Class II: Lack of Processing Control record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
8,069 adverse-event reports mention Tretinoin. Most often reported:
- Off label use · 953
- Drug ineffective · 841
- Pain · 585
- Product use in unapproved indication · 500
- Vomiting · 496
- Nausea · 441
Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗
NIH has funded 3 research projects with Tretinoin in the title, $351,149 in total (1987–2005). NIH RePORTER ↗
Plain-language guides from the US government: MedlinePlus: Tretinoin ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“I have gotten good result on the acne front with tretinoin and azelaic acid.”
“I was on 0.1% tretinoin and azelaic acid for 5 years, and it didn't touch my skin.”
“I use Tretinoin topically and have for 7 years. It's life changing.”
“Tretinoin for sure. I've been on it for a month and the results are literally miraculous.”
Tretinoin compared
Other options for skin & hair
Sources
- User reports: 50 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA drug label (DailyMed) ↗
- FDA adverse-event reports (FAERS) ↗
- FDA recalls ↗
- MedlinePlus (NIH) ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate